Home > Articles > Published articles > Association of α-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitus |
Date: | 2022 |
Abstract: | Background: Compelling evidence suggests that the fibroblast growth factor 23 (FGF23) / α-klotho axis is impaired in subjects with diabetes mellitus. We examined the relationship between parameters related to calcium/phosphate homeostasis, including FGF23 and α-klotho, and subclinical carotid atherosclerosis burden in type 1 diabetes mellitus (T1D) subjects. Methods: This cross-sectional study involved 226 subjects with T1D and 147 age-, sex- and plaque-matched, non-diabetic (non-T1D) subjects, both with normal renal function. Carotid ultrasound was performed to determine the presence and burden of atheromatous plaques. Concentrations of the intact form of FGF23 and α-klotho were assessed by ELISA. Calcium, phosphate, parathyroid hormone, and vitamin D levels were also determined. Negative binomial regression models were used to examine relationship between parameters studied and subclinical carotid atherosclerosis. Results: Only FGF23 was increased in T1D compared with non-diabetic subjects (> 2-fold; p < 0. 05). α-klotho was higher in subjects with subclinical carotid atherosclerosis (1. 4-fold, p < 0. 05). Regression analysis revealed that the log α-klotho concentration was positively associated with the presence of subclinical carotid atherosclerosis both in T1D subjects (incidence rate ratio [IRR]: 1. 41; 95% confidence interval [CI], 1. 06-1. 89; p < 0. 05) and in non-T1D subjects (IRR: 1. 65; 95% CI, 1. 02-2. 75; p < 0. 05). The models also showed that age, smoking and albuminuria-to-creatinine ratio were positively associated with subclinical carotid atherosclerosis in T1D subjects. Interestingly, sex-related protection against plaque was also revealed in T1D women. Conclusion: Higher α-klotho was associated with subclinical carotid atherosclerotic in the absence of kidney dysfunction. This finding also points to a new pathophysiological pathway involved in the development and progression of this complication. |
Grants: | Instituto de Salud Carlos III PI15/0625 Instituto de Salud Carlos III CB15/00071 Instituto de Salud Carlos III CPII18/00004 |
Note: | Altrea ajuts: Ministerio de Sanidad y Consumo; European Regional Development Fund (FEDER); CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM). |
Rights: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
Language: | Anglès |
Document: | Article ; recerca ; Versió publicada |
Subject: | Type 1 diabetes mellitus ; Mineral metabolism ; Fibroblast growth factor 23 ; α-klotho |
Published in: | Cardiovascular diabetology, Vol. 21 Núm. 1 (december 2022) , p. 207, ISSN 1475-2840 |
9 p, 994.7 KB |